Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

42 trials with published results (21%)

Research Maturity

126 completed trials (64% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.6%

11 terminated out of 196 trials

Success Rate

92.0%

+5.4% vs benchmark

Late-Stage Pipeline

20%

40 trials in Phase 3/4

Results Transparency

33%

42 of 126 completed with results

Key Signals

42 with results92% success11 terminated

Data Visualizations

Phase Distribution

156Total
Not Applicable (77)
Early P 1 (2)
P 1 (16)
P 2 (21)
P 3 (18)
P 4 (22)

Trial Status

Completed126
Unknown16
Recruiting15
Not Yet Recruiting15
Terminated11
Active Not Recruiting7

Trial Success Rate

92.0%

Benchmark: 86.6%

Based on 126 completed trials

Clinical Trials (196)

Showing 20 of 20 trials
NCT07845149Not Yet RecruitingPrimary

Demodex Mites in Acne Patients and Herbal Extract Susceptibility

NCT04031469Suspended

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

NCT07756957Phase 2Not Yet RecruitingPrimary

Safety of the Acne mRNA Vaccine in Adolescents 12 to 17 Years of Age With Moderate to Severe Acne

NCT06868615Not ApplicableRecruitingPrimary

AVAVA MIRIA General Use

NCT04582383Phase 4Active Not RecruitingPrimary

Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne

NCT06316297Phase 1RecruitingPrimary

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

NCT06909344Not ApplicableCompletedPrimary

577-nm Diode Laser in the Treatment of Non -Inflammatory Acne

NCT07752368Not ApplicableCompletedPrimary

A Clinical Trial Examining the Efficacy of a Novel Acne Treatment Serum

NCT07749469Not ApplicableRecruitingPrimary

Safety and Efficacy of Skincare Products for Managing Mild to Moderate Acne in Individuals With Sensitive Skin

NCT07735169Not Yet RecruitingPrimary

Clinical Observation of Skin Condition in Patients With Acne Vulgaris Using Ubiquinol, Pomegranate Peel Extract, Ceramide, and Salicylic Acid Emulsion

NCT07013747Phase 1RecruitingPrimary

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne

NCT07481019Not ApplicableNot Yet Recruiting

A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology

NCT07127523Not ApplicableNot Yet RecruitingPrimary

A Clinical Trial to Investigate the Efficacy and Safety of GenLabs' Social Renew on Improving Acne Symptoms and Skin Repair Among Healthy Adults

NCT07368764Not ApplicableActive Not RecruitingPrimary

The Suitability of Tience® for Treating Acne Scars

NCT06989840Phase 1RecruitingPrimary

Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne

NCT06992154Early Phase 1Not Yet RecruitingPrimary

Role of Akkermansia Muciniphila in Acne Vulgaris

NCT07341087Not ApplicableRecruiting

Skin Inflammation in (Peri)Menopause: A Probiotic Intervention Proof of Concept Trial

NCT07572331Not ApplicableCompleted

Clinical Study Evaluating the Safety and Effectiveness of the NIRA Laser M2.1 for the Treatment of Full-Face Wrinkles

NCT07089368Not ApplicableNot Yet RecruitingPrimary

Photodynamic Therapy With Topical Application of a Zn(II) Phthalocyanine (RLP068/Cl) and Red Light for the Treatment of Moderate-to-severe Acne Vulgaris

NCT07549828Not ApplicableNot Yet RecruitingPrimary

Sebum Metabolomics and Lipidomics for Clinical Applications

Scroll to load more

Research Network

Activity Timeline